Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: lada


Latent Autoimmune Diabetes in Youth Shows Greater Autoimmunity than Latent Autoimmune Diabetes in Adults: Evidence from a Nationwide, Multicenter, Cross-sectional Study

April 22nd 2022

A high prevalence of LADY exists in youth with T2D phenotype. Latent autoimmune diabetes forms a continuous age-related spectrum from LADY to LADA, in which LADY shows greater autoimmunity (Pediatric Diabetes)

Categories: News, Paediatrics
Tags: autoimmunity, lada, Type 2 Diabetes

Categories: Paediatrics
Tags: autoimmunity, lada, Type 2 Diabetes

Comparing the bone mineral density among male patients with latent autoimmune diabetes and classical type 1 and type 2 diabetes, and exploring risk factors for osteoporosis

January 3rd 2021

Compared with male patients with T2DM, lower BMDs were observed in patients with LADA and T1DM. Low BMI, uric acid, C-peptide levels, and high osteocalcin levels are risk factors for developing low BMD in male patients with diabetes (Journal of Endocrinological Investigation)

Categories: News, Pathology
Tags: lada, Osteoporosis, Type 1 Diabetes, Type 2 Diabetes

Categories: Pathology
Tags: lada, Osteoporosis, Type 1 Diabetes, Type 2 Diabetes

Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation

December 7th 2020

Patients with classic T1DM presented more often with symptoms, lower BMI and higher number of autoantibodies, which may be related to a more aggressive autoimmune process. Patients with LADA developed more frequently microvascular complications for the same disease duration, namely diabetic nephropathy, and had more often metabolic syndrome (Diabetology & Metabolic Syndrome)

Categories: News, Pathology
Tags: lada, Type 1 Diabetes

Categories: Pathology
Tags: lada, Type 1 Diabetes

Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: a cross sectional study

November 11th 2020

This is the first study offering a comparative evaluation of cardiac autonomic neuropathy among LADA, type 1 and type 2 diabetes, showing a lower risk of cardiac autonomic neuropathy in LADA compared to type 2 diabetes and similar compared to type 1 diabetes. This disparity was not due to differences in age, metabolic control or cardiovascular risk factors (Diabetic Medicine)

Categories: Cardiovascular, News
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Categories: Cardiovascular
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel

September 22nd 2020

General screening for LADA in newly diagnosed non–insulin-requiring diabetes and, importantly, that large randomized clinical trials are warranted (Diabetes Care)

Categories: Management, News
Tags: lada

Categories: Management
Tags: lada

Bone mineral density spectrum in individuals with type 1 diabetes, LADA , and type 2 diabetes

August 4th 2020

BMD values in T1D, LADA and T2D were in an increasing order of mention. Patients with autoimmune diabetes were more susceptible to osteoporosis. A lower C‐peptide level may be responsible for decreased BMD in individuals with autoimmune diabetes (Diabetes/Metabolism Research and Reviews)

Categories: News, Pathology
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Categories: Pathology
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults

February 5th 2020

At diabetes onset, adults with latent autoimmune diabetes have a lower risk of microvascular complications followed by a later higher risk of complications than do adults with type 2 diabetes, secondary to worse glycaemic control (The Lancet Diabetes & Endocrinology)

Categories: Cardiovascular, News
Tags: lada, Type 2 Diabetes

Categories: Cardiovascular
Tags: lada, Type 2 Diabetes

Immunological and clinical characteristics of latent autoimmune diabetes in the elderly

July 2nd 2019

Autoantibodies GADA and Znt8A may be useful markers in identifying a subgroup of older patients with a clinical presentation of diabetes which could be characterized as latent autoimmune diabetes in the elderly (Diabetes/Metabolism Research and Reviews)

Categories: Diagnosis, News
Tags: elderly, lada

Categories: Diagnosis
Tags: elderly, lada

Investigating optimal β‐cell‐preserving treatment in latent autoimmune diabetes in adults: Results from a 21‐month randomized trial

June 20th 2019

β‐cell function after intervention was similar in patients with insulin‐ and sitagliptin‐treated LADA, regardless of the strength of autoimmunity. Further, participants with low levels of GAD antibodies did not experience progressive deterioration of β‐cell function over a 21‐month period. Taken together, these findings could be useful for clinicians’ choices of treatment in people with LADA (Diabetes, Obesity and Metabolism)

Categories: News, Treatment
Tags: B Cell, insulin, lada, sitagliptin

Categories: Treatment
Tags: B Cell, insulin, lada, sitagliptin

Individuals Fulfilling Criteria for Type 2 Diabetes Rather Than LADA Display Transient Signs of Autoimmunity Preceding Diagnosis With Possible Clinical Implications: The HUNT Study

November 21st 2018

We demonstrate signs of transient, prediagnostic evidence of autoimmune activity in patients later diagnosed and classified as having type 2 diabetes. Compared with other participants with type 2 diabetes, this subgroup had earlier onset of diabetes and may have lower β-cell function with possible clinical implications (Diabetes Care)

Categories: News, Pathology
Tags: lada, Type 2 Diabetes

Categories: Pathology
Tags: lada, Type 2 Diabetes

Lower mortality and cardiovascular event rates in patients with latent autoimmune diabetes in adults (LADA) as compared with type 2 diabetes and insulin deficient diabetes

March 6th 2018

LADA seems to be associated with lower mortality and lower risk of cardiovascular events, compared with both T2D and IDD (Diabetes Research and Clinical Practice)

Categories: News, Pathology
Tags: lada, Type 2 Diabetes

Categories: Pathology
Tags: lada, Type 2 Diabetes

Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes

May 5th 2017

LADA is genetically closer to T1D than T2D, although the genetic load of T1D risk alleles is less than childhood-onset T1D, particularly at the major histocompatibility complex region, potentially accounting for the later disease onset. Our results show that the genetic spectrum of T1D extends into adult-onset diabetes, where it can clinically masquerade as T2D (BMC Medicine)

Categories: Genetics, News
Tags: lada, Type 2 Diabetes

Categories: Genetics
Tags: lada, Type 2 Diabetes

Persons with latent autoimmune diabetes in adults express higher dipeptidyl peptidase-4 activity compared to persons with type 2 and type 1 diabetes

September 22nd 2016

Persons with LADA express higher DPP-4 activity compared to persons with both type 1 and type 2 diabetes. The possible patophysiological role of DPP-4 in the LADA pathogenesis needs to be further evaluated (Diabetes Research and Clinical Practice)

Categories: News, Pathology
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Categories: Pathology
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9

January 14th 2015

The present study shows that the magnitude of stimulated insulin secretion in LADA is intermediate between that of type 1 and type 2 diabetes mellitus (BMC Endocrine Disorders)

Categories: News, Pathology
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Categories: Pathology
Tags: lada, Type 1 Diabetes, Type 2 Diabetes

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Boehringer IngelheimNapp DiabetesAstraZenecaNovo Nordisk

Silver Sponsors

Welsh Endocrinology and Diabetes Society (WEDS)Abbott Diabetes CareAbout Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors Empagliflozin exenatide GLP-1 RA GLP-1RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership